• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 SARS-CoV-2 蛋白质组的变异及其对 5 种主要 SARS-CoV-2 谱系在封锁前出现和传播的影响。

Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.

机构信息

Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502285, India.

Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502285, India.

出版信息

Infect Genet Evol. 2021 Sep;93:104973. doi: 10.1016/j.meegid.2021.104973. Epub 2021 Jun 18.

DOI:10.1016/j.meegid.2021.104973
PMID:34147651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8233849/
Abstract

SARS-CoV-2 is currently causing major havoc worldwide with its efficient transmission and propagation. To track the emergence as well as the persistence of mutations during the early stage of the pandemic, a comparative analysis of SARS-CoV-2 whole proteome sequences has been performed by considering manually curated 31,389 whole genome sequences from 84 countries. Among the 7 highly recurring (percentage frequency≥10%) mutations (Nsp2:T85I, Nsp6:L37F, Nsp12:P323L, Spike:D614G, ORF3a:Q57H, N protein:R203K and N protein:G204R), N protein:R203K and N protein: G204R are co-occurring (dependent) mutations. Nsp12:P323L and Spike:D614G often appear simultaneously. The highly recurring Spike:D614G, Nsp12:P323L and Nsp6:L37F as well as moderately recurring (percentage frequency between ≥1 and <10%) ORF3a:G251V and ORF8:L84S mutations have led to4 major clades in addition to a clade that lacks high recurring mutations. Further, the occurrence of ORF3a:Q57H&Nsp2:T85I, ORF3a:Q57H and N protein:R203K&G204R along with Nsp12:P323L&Spike:D614G has led to 3 additional sub-clades. Similarly, occurrence of Nsp6:L37F and ORF3a:G251V together has led to the emergence of a sub-clade. Nonetheless, ORF8:L84S does not occur along with ORF3a:G251V or Nsp6:L37F. Intriguingly, ORF3a:G251V and ORF8:L84S are found to occur independent of Nsp12:P323L and Spike:D614G mutations. These clades have evolved during the early stage of the pandemic and have disseminated across several countries. Further, Nsp10 is found to be highly resistant to mutations, thus, it can be exploited for drug/vaccine development and the corresponding gene sequence can be used for the diagnosis. Concisely, the study reports the SARS-CoV-2 antigens diversity across the globe during the early stage of the pandemic and facilitates the understanding of viral evolution.

摘要

SARS-CoV-2 目前通过高效传播和繁殖在全球范围内造成严重破坏。为了在大流行早期追踪突变的出现和持续存在,对来自 84 个国家的 31389 个全基因组序列进行了 SARS-CoV-2 全蛋白质组序列的比较分析。在 7 个高频(频率百分比≥10%)突变(Nsp2:T85I、Nsp6:L37F、Nsp12:P323L、Spike:D614G、ORF3a:Q57H、N 蛋白:R203K 和 N 蛋白:G204R)中,N 蛋白:R203K 和 N 蛋白:G204R 是共同发生(依赖)的突变。Nsp12:P323L 和 Spike:D614G 经常同时出现。高频 Spike:D614G、Nsp12:P323L 和 Nsp6:L37F 以及中度高频(频率百分比在≥1%至<10%之间)ORF3a:G251V 和 ORF8:L84S 突变导致除了缺乏高频突变的聚类之外,还出现了 4 个主要聚类。此外,ORF3a:Q57H&Nsp2:T85I、ORF3a:Q57H 和 N 蛋白:R203K&G204R 以及 Nsp12:P323L&Spike:D614G 的出现导致了 3 个额外的亚聚类。同样,Nsp6:L37F 和 ORF3a:G251V 的出现导致了一个亚聚类的出现。然而,ORF8:L84S 不会与 ORF3a:G251V 或 Nsp6:L37F 一起出现。有趣的是,ORF3a:G251V 和 ORF8:L84S 被发现与 Nsp12:P323L 和 Spike:D614G 突变无关。这些聚类在大流行早期阶段进化,并在多个国家传播。此外,Nsp10 被发现对突变高度耐受,因此可以用于药物/疫苗开发,并且可以使用相应的基因序列进行诊断。简而言之,该研究报告了大流行早期全球范围内 SARS-CoV-2 抗原的多样性,并促进了对病毒进化的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/fd3a4736b48b/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/75dad5047e34/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/9e1584a66a0f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/f669211a52c5/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/b7fb7cddede8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/4c9527130804/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/fd3a4736b48b/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/75dad5047e34/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/9e1584a66a0f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/f669211a52c5/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/b7fb7cddede8/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/4c9527130804/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/455b/8233849/fd3a4736b48b/gr5_lrg.jpg

相似文献

1
Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.全球 SARS-CoV-2 蛋白质组的变异及其对 5 种主要 SARS-CoV-2 谱系在封锁前出现和传播的影响。
Infect Genet Evol. 2021 Sep;93:104973. doi: 10.1016/j.meegid.2021.104973. Epub 2021 Jun 18.
2
Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts.SARS-CoV-2 氨基酸突变的地理分布及非人类宿主中七个不同进化枝的伴随进化。
Zoonoses Public Health. 2022 Nov;69(7):816-825. doi: 10.1111/zph.12971. Epub 2022 May 25.
3
The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.新型 SARS-CoV-2 在全球传播六个月后的分子变异程度。
Infect Genet Evol. 2021 Jul;91:104800. doi: 10.1016/j.meegid.2021.104800. Epub 2021 Mar 5.
4
Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.SARS-CoV-2 突变对蛋白结构和病毒内蛋白-蛋白相互作用的影响。
J Med Virol. 2021 Apr;93(4):2132-2140. doi: 10.1002/jmv.26597. Epub 2020 Nov 1.
5
Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.评估 SARS-CoV-2 基因组内的洲际突变热点和保守结构域。
Infect Genet Evol. 2021 Dec;96:105097. doi: 10.1016/j.meegid.2021.105097. Epub 2021 Oct 1.
6
Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.2020 年 12 月 1 日至 2021 年 3 月 15 日期间,各大陆与 SARS-CoV-2 变异体相关的死亡、发病和病死率。
Genes (Basel). 2021 Jul 12;12(7):1061. doi: 10.3390/genes12071061.
7
Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.对超过 10000 株 SARS-CoV-2 病毒进行全基因组分析揭示了全球遗传多样性和 NSP6 的靶标区域。
Brief Bioinform. 2021 Mar 22;22(2):1106-1121. doi: 10.1093/bib/bbab025.
8
Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.SARS-CoV-2 基因变异的进化追踪突显了稳定和不稳定突变之间的复杂平衡。
mBio. 2021 Aug 31;12(4):e0118821. doi: 10.1128/mBio.01188-21. Epub 2021 Jul 20.
9
Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins.预测 30229 株 SARS-CoV-2 菌株中前 10 种非同义变异对其蛋白的影响。
F1000Res. 2022 Jan 6;11:9. doi: 10.12688/f1000research.72904.2. eCollection 2022.
10
Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?阿尔及利亚和北非国家新冠病毒的基因组多样性:我们目前所知及预期如何?
Microorganisms. 2022 Feb 18;10(2):467. doi: 10.3390/microorganisms10020467.

引用本文的文献

1
Genetic characteristics of SARS-CoV-2 virus variants observed upon three waves of the COVID-19 pandemic in Ukraine between February 2021-January 2022.2021年2月至2022年1月乌克兰新冠疫情三波期间观察到的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒变体的遗传特征。
Heliyon. 2024 Feb 7;10(4):e25618. doi: 10.1016/j.heliyon.2024.e25618. eCollection 2024 Feb 29.
2
Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.主要关注和感兴趣的 SARS-CoV-2 变体的基因和蛋白质的定量突变分析。
Viruses. 2023 May 18;15(5):1193. doi: 10.3390/v15051193.
3
Analysis of co-occurring and mutually exclusive amino acid changes and detection of convergent and divergent evolution events in SARS-CoV-2.

本文引用的文献

1
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.人类 ACE2 受体多态性与对 SARS-CoV-2 的易感性改变。
Commun Biol. 2021 Apr 12;4(1):475. doi: 10.1038/s42003-021-02030-3.
2
A rational design of a multi-epitope vaccine against SARS-CoV-2 which accounts for the glycan shield of the spike glycoprotein.针对 SARS-CoV-2 的 Spike 糖蛋白糖盾的一种多表位疫苗的合理设计。
J Biomol Struct Dyn. 2022 Sep;40(15):7099-7113. doi: 10.1080/07391102.2021.1894986. Epub 2021 Mar 10.
3
The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中共现和互斥氨基酸变化的分析以及趋同和趋异进化事件的检测。
Comput Struct Biotechnol J. 2022;20:4238-4250. doi: 10.1016/j.csbj.2022.07.051. Epub 2022 Aug 5.
4
SARS-CoV-2 Amino Acid Mutations Detection in Greek Patients Infected in the First Wave of the Pandemic.在希腊第一波新冠疫情感染患者中检测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)氨基酸突变
Microorganisms. 2022 Jul 15;10(7):1430. doi: 10.3390/microorganisms10071430.
5
Identifying COVID-19 Severity-Related SARS-CoV-2 Mutation Using a Machine Learning Method.使用机器学习方法识别与新冠病毒疾病严重程度相关的严重急性呼吸综合征冠状病毒2突变
Life (Basel). 2022 May 28;12(6):806. doi: 10.3390/life12060806.
6
A bioinformatic approach of targeting SARS-CoV-2 replication by silencing a conserved alternative reserve of the orf8 gene using host miRNAs.通过使用宿主 microRNA 沉默 SARS-CoV-2 复制的保守备用 ORF8 基因的生物信息学方法。
Comput Biol Med. 2022 Jun;145:105436. doi: 10.1016/j.compbiomed.2022.105436. Epub 2022 Mar 24.
7
Structural biology of SARS-CoV-2: open the door for novel therapies.SARS-CoV-2 的结构生物学:为新型疗法开辟道路。
Signal Transduct Target Ther. 2022 Jan 27;7(1):26. doi: 10.1038/s41392-022-00884-5.
8
Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.揭示 SARS-CoV-2 未注释的 ORF 抗原中存在的有效表位,为基于表位的多价疫苗设计提供免疫信息学方法。
Front Immunol. 2021 Aug 23;12:692937. doi: 10.3389/fimmu.2021.692937. eCollection 2021.
刺突 D614G 突变增加了 SARS-CoV-2 对多种人类细胞类型的感染。
Elife. 2021 Feb 11;10:e65365. doi: 10.7554/eLife.65365.
4
D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.D614G 突变改变了 SARS-CoV-2 刺突构象,并增强了 S1/S2 连接处的蛋白酶切割。
Cell Rep. 2021 Jan 12;34(2):108630. doi: 10.1016/j.celrep.2020.108630. Epub 2020 Dec 26.
5
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.对印度新冠病毒基因组的分析揭示了刺突蛋白中D614G突变的流行情况,该突变预示着与跨膜丝氨酸蛋白酶2(TMPRSS2)的相互作用增加以及病毒传染性增强。
Front Microbiol. 2020 Nov 23;11:594928. doi: 10.3389/fmicb.2020.594928. eCollection 2020.
6
Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance.D614G 刺突变异株对免疫球蛋白 G、M 或 A 刺突血清学检测性能的影响。
J Infect Dis. 2021 Mar 3;223(5):802-804. doi: 10.1093/infdis/jiaa743.
7
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.SARS-CoV-2 刺突蛋白 D614G 突变增加了病毒粒子刺突密度和感染力。
Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.
8
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
9
Discovery of Drug-Like Ligands for the Mac1 Domain of SARS-CoV-2 Nsp3.发现 SARS-CoV-2 Nsp3 的 Mac1 结构域的类药物配体。
SLAS Discov. 2020 Dec;25(10):1162-1170. doi: 10.1177/2472555220960428. Epub 2020 Sep 28.
10
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.基于质谱的生物信息学预测器的基于序列的 SARS-CoV-2 疫苗靶标预测,可鉴定免疫原性 T 细胞表位。
Genome Med. 2020 Aug 13;12(1):70. doi: 10.1186/s13073-020-00767-w.